COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS - Stock were valued on the date of issuance using the Monte Carlo pricing model with the following assumptions (Details)	Jan. 10, 2025
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Percentage of right warrants	90.00%
Series A Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Percentage of right warrants	90.00%
Series B Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Percentage of right warrants	90.00%
Common Stock Price as of Issuance Date \| Series A Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	0.94
Common Stock Price as of Issuance Date \| Series B Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	0.94
Risk-Free Rate \| Series A Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	4.31
Risk-Free Rate \| Series B Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	4.27
Dividend Rate \| Series A Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	0
Dividend Rate \| Series B Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	0
Volatility \| Series A Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	88.9
Volatility \| Series B Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	97.19
Exercise Price \| Minimum \| Series A Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	1
Exercise Price \| Minimum \| Series B Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	2
Exercise Price \| Maximum \| Series A Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	2
Exercise Price \| Maximum \| Series B Right Warrants
COMMON STOCK, STOCK-BASED COMPENSATION AND WARRANTS
Warrants and rights outstanding	4

Cytosorbents Corp 10-Q